NetraMark Holdings Inc. develops artificial intelligence and machine learning solutions for the pharmaceutical industry principally in Canada. NetraMark Holdings Inc. is based in Toronto, Canada.
| Revenue (Most Recent Fiscal Year) | $0.62M |
| Net Income (Most Recent Fiscal Year) | $-2.45M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 132.50 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 93.79 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -906.70% |
| Net Margin (Trailing 12 Months) | -- |
| Return on Equity (Trailing 12 Months) | -543.76% |
| Return on Assets (Trailing 12 Months) | -333.03% |
| Current Ratio (Most Recent Fiscal Quarter) | 2.91 |
| Quick Ratio (Most Recent Fiscal Quarter) | 2.91 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | -- |
| Book Value per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.01 |
| Earnings per Share (Most Recent Fiscal Year) | $-0.07 |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.04 |
| Exchange | -- |
| Sector | -- |
| Industry | -- |
| Common Shares Outstanding | 86.25M |
| Free Float | -- |
| Market Capitalization | $81.09M |
| Average Volume (Last 20 Days) | 1493.95 |
| Beta (Past 60 Months) | -- |
| Percentage Held By Insiders (Latest Annual Proxy Report) | -- |
| Percentage Held By Institutions (Latest 13F Reports) | -- |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |